DEPLOYDatabase

Company

ReWalk Robotics

Wearable robotic exoskeleton for spinal cord injury patients.

Track ReWalk Robotics
HQ
Marlborough, MA
Status
duplicate (merged into lifeward)

The verified answer

As of Aug 2026, DEPLOY verifies ReWalk Robotics: 1 model, 1 deployment across 1 region. 1 source back the record.

CategoryExoskeletons

Models

1

Deployments

1

Overview

Wearable robotic exoskeleton for spinal cord injury patients. FDA-cleared ReWalk Personal 6.0. Public company (NASDAQ: RWLK).

Verified record

Verified deployments
1 deployment on file
Active incidents
None on file

Key facts

Robot

Wearable robotic exoskeleton for spinal cord injury patients

Technology

FDA-cleared ReWalk Personal 6.0

Stage

Public company listed on NASDAQ as RWLK

Data & sources

Web sources

1

1 source backing this record.View all →

ReWalk Robotics on the deployment map

View the global map

1 verified deployment across 1 region, newest verified Jun 2014. Explore where ReWalk Robotics's robots are operating, by place and type.

Free to use on your site, with a link back to DEPLOY.

View the full ReWalk Robotics deployment record →

Relationships

RReWalk RoboticsCustomer

Explainers

Plain-language answers to the questions people ask about ReWalk Robotics, from DEPLOY’s explainer library. Each is written in the language of the question and cross-checked against this registry.

What is an exoskeleton robot and how does it work?
An exoskeleton is a powered wearable robotic device worn by a human that assists or amplifies the wearer's movement. Exoskeletons are not autonomous robots: the wearer's intent drives every action. The category divides between medical exoskeletons (FDA-cleared for rehabilitation and personal mobility) and industrial exoskeletons (worn by workers to reduce fatigue and injury risk).Read the full explainer →
What is ReWalk Robotics and can you use it at home?
ReWalk Robotics is an Israeli-American medical exoskeleton company founded in 2001 whose ReWalk device is FDA-cleared for both clinical rehabilitation and personal home use by individuals with spinal cord injury. ReWalk is publicly traded on NASDAQ (RWLK). The company's FDA home-use clearance (2014) was the first for a powered exoskeleton in the United States.Read the full explainer →

Safety record

No incidents on record for ReWalk Robotics.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Operator customers (1)

Recent coverage

ReWalk Robotics in third-party press

Lifeward wins CE mark for ReWalk 7 personal endoskeleton - MassDevice

Sep 8, 2025

ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd. - Yahoo Finance

Sep 12, 2024

ReWalk Robotics rebrands to ‘Lifeward’ as portfolio expands - The Robot Report

Jan 30, 2024